Attenuated nuclear shrinkage in neurones with nuclear inclusions of SCA1 brains

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 5, 2003, Pages 597-601

  Nagaoka, U ^a,b   Uchihara, T ^a   Iwabuchi, K ^d   Konno, H ^e   Tobita, M ^f   Funata, N ^c   Yagishita, S ^d   Kato, T ^g  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d KANAGAWA REHABILITATION CENTER   (Japan)

^e Department of Neurology   (Japan)

^f MIYAGI NATIONAL HOSPITAL   (Japan)

^g YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLUTAMINE;

ADULT; AGED; ARTICLE; AUTOPSY; AUTOSOMAL DOMINANT DISORDER; BRAIN; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; NERVE DEGENERATION; NEUROPATHOLOGY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION;

ADULT; CELL NUCLEUS; FEMALE; HUMANS; INCLUSION BODIES; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PONS; SPINOCEREBELLAR ATAXIAS;

EID: 0038299961     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.5.597     Document Type: Article

References (21)

1. Orr HT, Chung MY, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-6.
2. Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 2000;23:217-47.
3. Kaytor M, Warren S. Aberrant protein deposition and neurological disease. J Biol Chem 1999;274:37507-10.
4. Sisodia SS. Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial? Cell 1998;95:1-4.
5. Yamamoto A, Lucas JJ, Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 2000;101:57-66.
6. Ona VO, Li M, Vonsattel JP, et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 1999;399:263-7.
7. Kim M, Lee H-S, LaForet G, et al. Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci 1999;19:964-73.
8. Saudou F, Finkbeiner S, Devys D, et al. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 1998;95:55-66.
9. Klement IA, Skinner PJ, Kaytor MD, et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 1998;95:41-53.
10. Kuemmerle S, Gutekunst C-A, Klein AM, et al. Huntingtin aggregates may not predict neuronal death in Huntington's disease. Ann Neurol 1999;46:842-9.
11. Takahashi J, Tanaka J, Arai K, et al. Recruitment of non-expanded polyglutamine proteins in intranuclear aggregates of neuronal intranuclear hyaline inclusion disease. J Neuropathol Exp Neurol 2001;60:369-76.
12. Takahashi H, Egawa S, Piao Y-S, et al. Neuronal nuclear alterations in dentatorubral-pallidoluysian atrophy: ultrastructural and morphometric studies of the cerebellar granule cells. Brain Res 2001;919:12-19.
13. Uchihara T, Iwabuchi K, Funata N, et al. Attenuated nuclear shrinkage in neurons with nuclear aggregates - a morphometric study on pontine neurons of Machado-Joseph disease brains. Exp Neurol 2002;178:124-8.
14. Uchihara T, Tanaka J, Funata N, et al. Influence of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases. Acta Neuropathol 2003;105:103-8.
15. Roos RAC, Bots GTAM. Nuclear membrane indentations in Huntington's chorea. J Neurol Sci 1983;61:37-47.
16. Bots GTAM, Bruyn GW. Neuropathological changes of the nucleus accumbens in Huntington's chorea. Acta Neuropathol 1981;55:21-2.
17. Davies SW, Turmaine M, Cozens BA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997;90:537-48.
18. Cummings CJ, Reinstein E, Sun Y, et al. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 1999;24:879-92.
19. Fujigasaki H, Uchihara T, Koyano S, et al. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains. Exp Neurol 2000;165:248-56.
20. Takahashi J, Fukuda T, Tanaka J, et al. Neuronal intranuclear hyaline inclusion disease with polyglutamine immunoreactive inclusions. Acta Neuropathol 2000;99:589-94.
21. Cummings CJ, Mancini MA, Antalffy B, et al. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet 1998;19:148-54.